DSOL Stock Overview

A lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. More details

DSOL fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Latest financial reports are more than a year old

Does not have a meaningful market cap ($89K)

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Drug Free Solution, Inc. Competitors

Novo Integrated Sciences

OTCPK:NVOS

US$1.6m

Medical Care Technologies

OTCPK:MDCE

US$2.9m

Ontrak

NasdaqCM:OTRK

US$7.4m

Acro Biomedical

OTCPK:ACBM

US$42.0k

Price History & Performance

Summary of share price highs, lows and changes for Drug Free Solution
Historical stock prices
Current Share Price	US$0.0002
52 Week High	US$0.0002
52 Week Low	US$0.0002
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-98.86%
Change since IPO	-99.96%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	DSOL	US Healthcare	US Market
7D	0%	0.8%	3.2%
1Y	n/a	-4.0%	24.2%

Return vs Industry: Insufficient data to determine how DSOL performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how DSOL performed against the US Market.

Price Volatility

Is DSOL's price volatile compared to industry and market?
DSOL volatility
DSOL Average Weekly Movement	n/a
Healthcare Industry Average Movement	7.9%
Market Average Movement	6.5%
10% most volatile stocks in US Market	18.9%
10% least volatile stocks in US Market	3.2%

Stable Share Price: DSOL's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine DSOL's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Jessica Bass	www.drugfreesolution.com

Drug Free Solution, Inc., a lifestyle company, delivers proprietary emotional wellness technology, known as Living Breath Process. Its Living Breath Process is a three-step process that combines self-analysis, breath, and language addressing various markets, including addiction/prevention, self help, emotional wellness, and lifestyle. The company also offers the Living Breath Series of programs with products, education, and services.

Drug Free Solution, Inc. Fundamentals Summary

How do Drug Free Solution's earnings and revenue compare to its market cap?
DSOL fundamental statistics
Market cap	US$88.89k
Earnings (TTM)	-US$867.71k
Revenue (TTM)	US$2.10k

0.0x

P/S Ratio

0.0x

P/E Ratio

Is DSOL overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DSOL income statement (TTM)
Revenue	US$2.10k
Cost of Revenue	US$212.65k
Gross Profit	-US$210.55k
Other Expenses	US$657.16k
Earnings	-US$867.71k

Last Reported Earnings

Feb 28, 2014

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did DSOL perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/19 06:04
End of Day Share Price	2024/11/19 00:00
Earnings	2014/02/28
Annual Earnings	2013/05/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Drug Free Solution, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution